News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,717 Results
Type
Article (5120)
Company Profile (17)
Press Release (220580)
Section
Business (82271)
Career Advice (463)
Deals (15047)
Drug Delivery (8)
Drug Development (19120)
Employer Resources (30)
FDA (3682)
Job Trends (3908)
News (120233)
Policy (7514)
Tag
Academia (305)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14786)
ALS (20)
Alzheimer's disease (254)
Antibody-drug conjugate (ADC) (11)
Approvals (3701)
Artificial intelligence (42)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2867)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (454)
Cardiovascular disease (24)
Career advice (395)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16069)
Collaboration (172)
Compensation (170)
Complete response letters (2)
COVID-19 (305)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (527)
Depression (6)
Diabetes (43)
Diagnostics (2044)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (16)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40904)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37865)
Executive appointments (315)
FDA (3940)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (414)
Guidances (18)
Healthcare (5044)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (321)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7824)
IRA (3)
Job creations (1123)
Job search strategy (362)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2336)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (50)
MASH (28)
Medical device (3863)
Medtech (3864)
Mergers & acquisitions (7430)
Metabolic disorders (124)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (351)
NextGen: Class of 2025 (1689)
Non-profit (736)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (32)
Peanut (5)
People (24647)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4792)
Phase II (6980)
Phase III (5563)
Pipeline (568)
Policy (9)
Postmarket research (628)
Preclinical (1886)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1874)
Recruiting (8)
Regulatory (5127)
Reports (14)
Research institute (306)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1012)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (36)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (57)
Last 7 days (219)
Last 30 days (710)
Last 365 days (9945)
2025 (3188)
2024 (11038)
2023 (13203)
2022 (18677)
2021 (19702)
2020 (18258)
2019 (13237)
2018 (10233)
2017 (10022)
2016 (9182)
2015 (12149)
2014 (9601)
2013 (7714)
2012 (8340)
2011 (8812)
2010 (8646)
Location
Africa (187)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11476)
Australia (1615)
California (1985)
Canada (713)
China (73)
Colorado (84)
Connecticut (95)
Delaware (30)
Europe (24590)
Florida (285)
Georgia (34)
Idaho (23)
Illinois (117)
India (7)
Indiana (64)
Iowa (2)
Japan (74)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1592)
Michigan (85)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (24)
New Hampshire (16)
New Jersey (573)
New Mexico (5)
New York (479)
North Carolina (332)
North Dakota (3)
Northern California (944)
Ohio (59)
Oklahoma (5)
Oregon (4)
Pennsylvania (350)
Puerto Rico (1)
Rhode Island (13)
South America (280)
South Carolina (5)
Southern California (717)
Tennessee (41)
Texas (231)
United States (7184)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (176)
West Virginia (2)
Wisconsin (25)
225,717 Results for "geron corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Geron Corporation Announces Departure of Chief Executive Officer
March 12, 2025
·
5 min read
Press Releases
Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
February 26, 2025
·
18 min read
Press Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
2 min read
Press Releases
Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025
March 31, 2025
·
1 min read
Press Releases
Geron to Participate at Upcoming Investor Conferences in March 2025
February 21, 2025
·
1 min read
Business
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
Geron Corporation reported financial results and business highlights for the first quarter 2024.
May 2, 2024
·
13 min read
FDA
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder
Approved for patients with low- to intermediate-risk myelodysplastic syndromes, Geron’s Rytelo is the first telomerase inhibitor to hit the market and the company’s first approved drug after 34 years in business.
June 7, 2024
·
2 min read
·
Kate Goodwin
Press Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 19, 2025
March 20, 2025
·
2 min read
Biotech Bay
Geron to Participate at Upcoming Investor Conferences in April 2024
Geron Corporation announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences.
April 3, 2024
·
1 min read
Biotech Bay
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 20, 2024
Geron Corporation, a commercial stage biopharmaceutical company, reported that it has granted non-statutory stock options to purchase an aggregate of 222,660 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.
June 20, 2024
·
2 min read
1 of 22,572
Next
